Murine autoimmune hearing loss mediated by CD4+ T cells specific for β-tubulin

Clinical Immunology

Volumn 138, Issue 2, 2011, Pages 222-230

  Zhou, Bin ^a   Kermany, Mohammad Habiby ^a   Glickstein, Jonathan ^a   Cai, Qing ^a   Cai, Chun ^a   Zhou, Yixuan ^a   Nair, Usha ^a   Kim, Jun Woo ^a   Kim, Patrick ^a   Liu, Wenxia ^a   Kanangat, Siva ^a   Yoo, Tai June ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Autoimmune inner ear disease; Autoimmunity; Hearing loss

Indexed keywords

BETA TUBULIN; GAMMA INTERFERON; PEPTIDASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY RESPONSE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; BRAIN STEM RESPONSE; CD4+ T LYMPHOCYTE; CELL LOSS; COCHLEA; CONTROLLED STUDY; FEMALE; HAIR CELL; HEARING LOSS; IMMUNIZATION; INNER EAR; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; BRAIN STEM; CD4-POSITIVE T-LYMPHOCYTES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HAIR CELLS, AUDITORY, INNER; HEARING LOSS, SENSORINEURAL; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; TUBULIN;

EID: 79251595141     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.11.007     Document Type: Article

References (47)

1. Mathis D., Benoist C. Levees of immunological tolerance. Nat. Immunol. Jan 2010, 11(1):3-6.
2. McCabe B.F. Autoimmune sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 1979, 88:585-589.
3. Buniel M.C., Geelan-Hansen K., Weber P.C., Tuohy V.K. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 2009, 1(3):425-434.
4. Loveman D.M., de Comarmond C., Cepero R., Baldwin D.M. Autoimmune sensorineural hearing loss: clinical course and treatment outcome. Semin. Arthritis Rheum. 2004, 34(2):538-543.
5. Bloch D., San Martin J., Rauch S., Moscicki R., Bloch K. Serum antibodies to heat shock protein 70 in sensorineural hearing loss. Arch. Otolaryngol. Head Neck Surg. 1995, 121:1167-1171.
6. Billings P., Shin S., Harris J. Assessing the role of anti-hsp70 in cochlear impairment. Hear. Res. 1998, 126:210-213.
7. Yoo T., Tomoda K., Stuart J., Cremer T., Townes A., Kang A. Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann. Otol. Rhinol. Laryngol. 1983, 92:267-271.
8. Yoo T., Yazawa Y., Tomoda K., Floyd R. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science 1983, 222:65-67.
9. Baek M., Park H., Johnson J., Altuntas C., Jane-Wit D., Jaini R., Solares C., Thomas D., Ball E., Robertson N., Morton C., Hughes G., Tuohy V. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J. Immunol. 2006, 15(177(6)):4203-4210.
10. Solares C., Edling A., Johnson J., Baek M., Hirose K., Hughes G., Tuohy V. Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. J. Clin. Invest. 2004, 113(8):1210-1217.
11. Yoo T., Tanaka H., Kwon S., Krug M., Yazawa Y., Suzuki M., Kitajima K. β-tubulin as an autoantigen for autoimmune inner ear disease. Meniere's Dis. 1999, 529-535.
12. Yoo T., Shea J., Ge X., Kwon S., Yazawa Y., Sener O., Mora F., Mora R., Mora M., Barbieri M., Du X. Presence of autoantibodies in the sera of Meniere's disease. Ann. Otol. Rhinol. Laryngol. 2001, 110:425-429.
13. Yoo T., Du X., Kwon S. Molecular mechanism of autoimmune hearing loss. Acta Otolaryngol. Suppl. 2002, (548):3-9.
14. Du X., Yoo T., Mora R. Distribution of beta-tubulin in guinea pig inner ear. ORL 2003, 65:7-16.
15. Cai Q., Du X., Zhou B., Cai C., Kermany M., Yoo T. Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease. ORL J. Otorhinolaryngol. Relat. Spec. 2009, 71(3):135-141.
16. Arnold W., Pfaltz R., Altermatt H. Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders. Acta Otolaryngol. 1985, 99:437-444.
17. Soliman A. Experimental autoimmune inner ear disease. Laryngoscope 1989, 99:188-193.
18. McCabe B., McCormick K.J. Tests for autoimmune disease in otology. Am. J. Otol. 1984, 5:447-449.
19. Hughes G., Barna B., Kinney S., Calabrese L., Nalepa N. Predictive value of laboratory tests in "autoimmune" inner ear disease: preliminary report. Laryngoscope 1986, 96:502-505.
20. Lorenz R. Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss. J. Neuroimmunol. 2002, 130:173-178.
21. Harris J. Experimental autoimmune sensorineural hearing loss. Laryngoscope 1987, 97:63-76.
22. Soliman A. The use of immunofluorescence in the non-decalcified frozen guinea pig cochlea to detect autoantibodies in inner ear disorders. Arch. Otorhinolaryngol. 1987, 244:241-245.
23. Yamanobe S., Harris J. Spontaneous remission in experimental autoimmune labyrinthitis. Ann. Otol. Rhinol. Laryngol. 1992, 101:1007-1014.
24. Gloddek B., Gloddek J., Arnold W. Induction of an inner-ear-specific autoreactive T-cell line for the diagnostic evaluation of an autoimmune disease of the inner ear. Ann. NY Acad. Sci. 1997, 830:266-276.
25. Gloddek B., Gloddek J., Arnold W. A rat T-cell line that mediates autoimmune disease of the inner ear in the Lewis rat. ORL J. Otorhinolaryngol. Relat. Spec. 1999, 61:181-187.
26. Ogata Y., Slepecky N. Immunocytochemical comparison of posttranslationally modified forms of tubulin in the vestibular end-organs of the gerbil: tyrosinated, acetylated and polyglutamylated tubulin. Hear. Res. 1995, 86:125-131.
27. Furness D., Hackney C., Steyger P. Organization of microtubules in cochlear hair cells. J. Electron. Microsc. Tech. 1990, 15:261-279.
28. Cleveland D.W., Sullivan K.F. Molecular biology and genetics of tubulin. Annu. Rev. Biochem. 1985, 54:331-365.
29. Hallworth R., McCoy M., Polan-Curtain J. Tubulin expression in the developing and adult gerbil organ of Corti. Hear. Res. 2000, 139:31-41.
30. Molea D., Stone J., Rubel E. Class III β-tubulin expression in sensory and nonsensory regions of the developing avian inner ear. J. Comp. Neurol. 1999, 406:183-198.
31. Xia M., Zhang H., Liu F., Yin H., Xu A. Impaired CD4+CD25+ regulatory T cell activity in the peripheral blood of patients with autoimmune sensorineural hearing loss. Eur. Arch. Otorhinolaryngol. 2008, 265(9):1027-1033.
32. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010, 11(1):7-13.
33. Wan Y. Regulatory T cells: immune suppression and beyond. Cell. Mol. Immunol. 2010, 7(3):204-210.
34. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immun. 2002, 3:135-142.
35. Akdis M., Akdis C. Therapeutic manipulation of immune tolerance in allergic disease. Nat. Rev. Drug Discov. 2009, 8(8):645-660.
36. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
37. Antony P., Restifo N. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J. Immunother. 2005, 28:120-128.
38. Oldenhove G., de Heusch M., Urbain-Vansanten G., Urbain J., Maliszewski C., Leo O., Moser M. CD4+CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 2003, 198:259-266.
39. Yang Z., Novak A., Stenson M., Witzig T., Ansell S. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006, 107:3639-3646.
40. Liu W., Truong N., Grossman W. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 2005, 116:1106-1115.
41. Kim J., Rudenky A. The role of the transcription for Foxp3 in the development of regulatory Tcells. Immunol. Rev. 2006, 212:86-92.
42. Bacchetta R., Passerini L., Gambineri F. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 2006, 116:1713-1722.
43. Bennett C., Ochs H. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 2001, 13:533-538.
44. Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J. Clin. Invest. 2003, 112:1310-1312.
45. Hong J., Li N., Zhang X., Zheng B., Zhang J. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl Acad. Sci. USA 2005, 102:6449-6454.
46. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J., Roncarolo M. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
47. Chen Y., Kuchroo V., Inobe J., Hafler D., Weiner H. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.